中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
19期
1330-1333
,共4页
栾晓梅%张瑶%王诗卓%王宁%李威%张乔%魏恒%张淑兰
欒曉梅%張瑤%王詩卓%王寧%李威%張喬%魏恆%張淑蘭
란효매%장요%왕시탁%왕저%리위%장교%위항%장숙란
抗原,肿瘤%癌,鳞状细胞%宫颈肿瘤%预后%血清
抗原,腫瘤%癌,鱗狀細胞%宮頸腫瘤%預後%血清
항원,종류%암,린상세포%궁경종류%예후%혈청
Antigens,neoplasms%Carcinoma,squamous cell%Uterine cervical neoplasms%Prognosis%Serum
目的 探讨鳞状细胞癌抗原(SCC-Ag)在宫颈鳞状细胞癌辅助诊断、治疗及预后监测中的临床意义.方法 收集2008年8月至2010年10月于中国医科大学附属盛京医院妇科病房治疗的宫颈鳞癌病例1195例、非鳞癌类型宫颈癌54例,宫颈上皮内瘤变病例325例及健康妇女病例69例的血清SCC-Ag浓度,回顾性分析其与宫颈鳞状细胞癌临床病理特征的相关性,及其在诊断、治疗和随访监测中的水平变化.结果 血清SCC-Ag对于宫颈鳞状细胞癌诊断的敏感度和特异度分别为62.32%和90.10%,其对宫颈癌诊断的最佳临界值为1.45 μg/L.治疗前血清SCC-Ag水平在宫颈鳞状细胞癌的临床分期、组织分化程度、浸润深度、淋巴结转移间差异均有统计学意义(均P <0.01).106例进行根治性手术及264例接受放化疗的宫颈鳞癌患者治疗后血清SCC-Ag水平明显下降,与治疗前比较差异均有统计学意义(均P<0.05).血清SCC-Ag浓度与人乳头瘤病毒(HPV)机会性感染存在关联(均P >0.05).治疗前血清SCC-Ag浓度用于估计早期宫颈鳞癌淋巴结转移和宫颈鳞癌预后风险的最佳临界值分别为2.15和12.1 μg/L.结论 SCC-Ag是宫颈鳞癌较特异的肿瘤标志物,与宫颈鳞癌的各项临床病理特征相关,对宫颈鳞癌的辅助诊断、治疗效果评价以及预后监测具有重要的临床参考价值.
目的 探討鱗狀細胞癌抗原(SCC-Ag)在宮頸鱗狀細胞癌輔助診斷、治療及預後鑑測中的臨床意義.方法 收集2008年8月至2010年10月于中國醫科大學附屬盛京醫院婦科病房治療的宮頸鱗癌病例1195例、非鱗癌類型宮頸癌54例,宮頸上皮內瘤變病例325例及健康婦女病例69例的血清SCC-Ag濃度,迴顧性分析其與宮頸鱗狀細胞癌臨床病理特徵的相關性,及其在診斷、治療和隨訪鑑測中的水平變化.結果 血清SCC-Ag對于宮頸鱗狀細胞癌診斷的敏感度和特異度分彆為62.32%和90.10%,其對宮頸癌診斷的最佳臨界值為1.45 μg/L.治療前血清SCC-Ag水平在宮頸鱗狀細胞癌的臨床分期、組織分化程度、浸潤深度、淋巴結轉移間差異均有統計學意義(均P <0.01).106例進行根治性手術及264例接受放化療的宮頸鱗癌患者治療後血清SCC-Ag水平明顯下降,與治療前比較差異均有統計學意義(均P<0.05).血清SCC-Ag濃度與人乳頭瘤病毒(HPV)機會性感染存在關聯(均P >0.05).治療前血清SCC-Ag濃度用于估計早期宮頸鱗癌淋巴結轉移和宮頸鱗癌預後風險的最佳臨界值分彆為2.15和12.1 μg/L.結論 SCC-Ag是宮頸鱗癌較特異的腫瘤標誌物,與宮頸鱗癌的各項臨床病理特徵相關,對宮頸鱗癌的輔助診斷、治療效果評價以及預後鑑測具有重要的臨床參攷價值.
목적 탐토린상세포암항원(SCC-Ag)재궁경린상세포암보조진단、치료급예후감측중적림상의의.방법 수집2008년8월지2010년10월우중국의과대학부속성경의원부과병방치료적궁경린암병례1195례、비린암류형궁경암54례,궁경상피내류변병례325례급건강부녀병례69례적혈청SCC-Ag농도,회고성분석기여궁경린상세포암림상병리특정적상관성,급기재진단、치료화수방감측중적수평변화.결과 혈청SCC-Ag대우궁경린상세포암진단적민감도화특이도분별위62.32%화90.10%,기대궁경암진단적최가림계치위1.45 μg/L.치료전혈청SCC-Ag수평재궁경린상세포암적림상분기、조직분화정도、침윤심도、림파결전이간차이균유통계학의의(균P <0.01).106례진행근치성수술급264례접수방화료적궁경린암환자치료후혈청SCC-Ag수평명현하강,여치료전비교차이균유통계학의의(균P<0.05).혈청SCC-Ag농도여인유두류병독(HPV)궤회성감염존재관련(균P >0.05).치료전혈청SCC-Ag농도용우고계조기궁경린암림파결전이화궁경린암예후풍험적최가림계치분별위2.15화12.1 μg/L.결론 SCC-Ag시궁경린암교특이적종류표지물,여궁경린암적각항림상병리특정상관,대궁경린암적보조진단、치료효과평개이급예후감측구유중요적림상삼고개치.
Objective To explore the clinical significance of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis,treatment and prognosis of cervical squamous cell carcinoma Methods The serum SCC-Ag concentrations were measured for 1195 patients with cervical squamous cell carcinoma,54patients with non-squamous cell type cervical cancer,325 patients with cervical intraepithelial neoplasm and 69 healthy women treated at Gynecology Ward of Shengjing Hospital,China Medical University from August 2008 to October 2010.And the correlations with their clinical pathological features of squamous cell carcinoma were analyzed and the changes in the diagnosis,treatment and prognosis monitored. Results Serum SCC-Ag in patients with cervical squamous cell carcinoma showed a sensitivity of 62.32% and a specificity of 90.10% with the optimal cutoff point of diagnosis at 1.45 μg/L.The differences of pretreatment serum SCC-Ag levels were statistically significant in clinical stage,histological differentiation,depth of invasion and lymph node metastasis ( P < 0.01 ).The posttreatment serum SCC-Ag levels of 106 patients undergoing radical surgery and 264 patients on chemotherapy significantly decreased and were significant different with their pretreatment levels ( P < 0.05 ).There was no relationship of serum SCC-Ag levels and human papillomavirus (HPV) opportunistic infection (all P > 0.05 ).The best threshold values of pretreatment serum SCC-Ag concentration for predicting early postoperative cervical lymph node metastasis and prognosis of cervical cancer were 2.15 and 12.1 μg/L respectively.Conclusion As a relatively specific tumor maker for cervical squamous cell carcinoma,squamous cell carcinoma antigen is correlated with clinicopathological features of cervical squamous cell carcinoma.And it has important clinical reference values in the diagnosis,prognosis,follow-up evaluation and treatment monitoring of cervical squamous cell carcinoma.